127 related articles for article (PubMed ID: 2101846)
21. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
Elbaz D
Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
[TBL] [Abstract][Full Text] [Related]
22. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
Kraft SP; Lang AE
CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm].
Grandas F; Elston J; Quinn N; Marsden CD
Neurologia; 1989; 4(6):194-9. PubMed ID: 2637760
[TBL] [Abstract][Full Text] [Related]
24. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
Ziak P
Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
[TBL] [Abstract][Full Text] [Related]
25. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
Novis SA; De Mattos JP; De Rosso AL
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
[TBL] [Abstract][Full Text] [Related]
26. [The treatment of blepharospasm with botulinum toxin A].
Költringer P; Haselwander H; Reisecker F
Wien Klin Wochenschr; 1990 Jul; 102(14):403-7. PubMed ID: 2382447
[TBL] [Abstract][Full Text] [Related]
27. Treatment of blepharospasm with medication, surgery and type A botulinum toxin.
Arthurs B; Flanders M; Codère F; Gauthier S; Dresner S; Stone L
Can J Ophthalmol; 1987 Feb; 22(1):24-8. PubMed ID: 3815152
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin treatment of blepharospasm.
Elston JS
Adv Neurol; 1988; 50():579-81. PubMed ID: 3400511
[No Abstract] [Full Text] [Related]
29. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
Dutton JJ; Buckley EG
Ophthalmology; 1988 Nov; 95(11):1529-34. PubMed ID: 3211461
[TBL] [Abstract][Full Text] [Related]
30. The use of botulinum toxin type A for the treatment of facial spasm.
Serrano LA
Bol Asoc Med P R; 1993; 85(1-3):7-11. PubMed ID: 8060446
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment of blepharospasm with botulinum toxin type A.
Nüssgens Z; Roggenkämper P
Ger J Ophthalmol; 1995 Nov; 4(6):363-7. PubMed ID: 8751102
[TBL] [Abstract][Full Text] [Related]
32. Supramaximal doses of botulinum toxin for refractory blepharospasm.
Levy RL; Berman D; Parikh M; Miller NR
Ophthalmology; 2006 Sep; 113(9):1665-8. PubMed ID: 16828511
[TBL] [Abstract][Full Text] [Related]
33. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study.
Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Messina C
Mov Disord; 1996 Jan; 11(1):27-31. PubMed ID: 8771064
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin in the treatment of dystonic tics.
Jankovic J
Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
[TBL] [Abstract][Full Text] [Related]
35. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
36. Acquired blepharoptosis secondary to essential blepharospasm.
Bodker FS; Olson JJ; Putterman AM
Ophthalmic Surg; 1993 Aug; 24(8):546-50. PubMed ID: 8233320
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.
Iwashige H; Nemeto Y; Takahashi H; Maruo T
Jpn J Ophthalmol; 1995; 39(4):424-31. PubMed ID: 8926651
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
Burbaud P; Arnaud A; Burbaud A; Lagueny A
J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
[TBL] [Abstract][Full Text] [Related]
39. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
Dresel C; Haslinger B; Castrop F; Wohlschlaeger AM; Ceballos-Baumann AO
Brain; 2006 Jan; 129(Pt 1):36-46. PubMed ID: 16280353
[TBL] [Abstract][Full Text] [Related]
40. Altered functional connectivity in blepharospasm/orofacial dystonia.
Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
